Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine
- PMID: 31505626
- PMCID: PMC6736152
- DOI: 10.1093/cid/ciz474
Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine
Erratum in
-
Erratum.Clin Infect Dis. 2020 Feb 14;70(5):993. doi: 10.1093/cid/ciz1222. Clin Infect Dis. 2020. PMID: 31942605 Free PMC article. No abstract available.
Abstract
Background: Historically, Nigeria has experienced large bacterial meningitis outbreaks with high mortality in children. Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae are major causes of this invasive disease. In collaboration with the World Health Organization, we conducted longitudinal surveillance in sentinel hospitals within Nigeria to establish the burden of pediatric bacterial meningitis (PBM).
Methods: From 2010 to 2016, cerebrospinal fluid was collected from children <5 years of age, admitted to 5 sentinel hospitals in 5 Nigerian states. Microbiological and latex agglutination techniques were performed to detect the presence of pneumococcus, meningococcus, and H. influenzae. Species-specific polymerase chain reaction and serotyping/grouping were conducted to determine specific causative agents of PBM.
Results: A total of 5134 children with suspected meningitis were enrolled at the participating hospitals; of these 153 (2.9%) were confirmed PBM cases. The mortality rate for those infected was 15.0% (23/153). The dominant pathogen was pneumococcus (46.4%: 71/153) followed by meningococcus (34.6%: 53/153) and H. influenzae (19.0%: 29/153). Nearly half the pneumococcal meningitis cases successfully serotyped (46.4%: 13/28) were caused by serotypes that are included in the 10-valent pneumococcal conjugate vaccine. The most prevalent meningococcal and H. influenzae strains were serogroup W and serotype b, respectively.
Conclusions: Vaccine-type bacterial meningitis continues to be common among children <5 years in Nigeria. Challenges with vaccine introduction and coverage may explain some of these finding. Continued surveillance is needed to determine the distribution of serotypes/groups of meningeal pathogens across Nigeria and help inform and sustain vaccination policies in the country.
Keywords: Nigeria; meningitis; meningococcus; neumococcus; pediatric.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures



Similar articles
-
Etiology of Bacterial Meningitis Among Children <5 Years Old in Côte d'Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction.Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S114-S120. doi: 10.1093/cid/ciz475. Clin Infect Dis. 2019. PMID: 31505624 Free PMC article.
-
Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lomé, Togo.Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S97-S104. doi: 10.1093/cid/ciz473. Clin Infect Dis. 2019. PMID: 31505623 Free PMC article.
-
Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S133-S139. doi: 10.1093/cid/ciz598. Clin Infect Dis. 2019. PMID: 31505636 Free PMC article.
-
Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis.Vaccine. 2018 Sep 18;36(39):5846-5857. doi: 10.1016/j.vaccine.2018.07.037. Epub 2018 Aug 23. Vaccine. 2018. PMID: 30145101
-
Effect of vaccines on bacterial meningitis worldwide.Lancet. 2012 Nov 10;380(9854):1703-11. doi: 10.1016/S0140-6736(12)61187-8. Lancet. 2012. PMID: 23141619 Review.
Cited by
-
Molecular characterization of Streptococcus pneumoniae causing disease among children in Nigeria during the introduction of PCV10 (GSK).Microb Genom. 2023 Sep;9(9):001094. doi: 10.1099/mgen.0.001094. Microb Genom. 2023. PMID: 37712828 Free PMC article.
-
Epidemic forecast and preparedness for explosive-cerebrospinal meningitis outbreak in Nigeria using the preventive vaccination strategy.Afr J Lab Med. 2023 Nov 17;12(1):2086. doi: 10.4102/ajlm.v12i1.2086. eCollection 2023. Afr J Lab Med. 2023. PMID: 38058850 Free PMC article. Review.
-
Estimating the global and regional burden of meningitis in children caused by Haemophilus influenzae type b: A systematic review and meta-analysis.J Glob Health. 2022 Mar 5;12:04014. doi: 10.7189/jogh.12.04014. eCollection 2022. J Glob Health. 2022. PMID: 35265327 Free PMC article.
-
The Burden of Invasive Bacterial Disease and the Impact of 10-Valent Pneumococcal Conjugate Vaccine in Children <5 years hospitalized for Meningitis in Lusaka, Zambia, 2010-2019.J Infect Dis. 2021 Sep 1;224(12 Suppl 2):S275-S284. doi: 10.1093/infdis/jiab193. J Infect Dis. 2021. PMID: 34469553 Free PMC article.
-
Prevalence, aetiology, vaccination coverage and spatio-temporal pattern among patients admitted with acute bacterial meningitis to the sentinel hospital surveillance network in Yemen, 2014-20, before and during the civil war.Int J Epidemiol. 2023 Aug 2;52(4):1175-1186. doi: 10.1093/ije/dyad047. Int J Epidemiol. 2023. PMID: 37128839 Free PMC article.
References
-
- Omeh DJOB, Omeh CK. Reccuring epidemics of meningococcal meningitis in African meningitis belt: a review of challenges and prospects. JAMMR 2017; 22:1–12
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources